BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35229908)

  • 1. FKRP directed fibronectin glycosylation: A novel mechanism giving insights into muscular dystrophies?
    Boyd A; Montandon M; Wood AJ; Currie PD
    Bioessays; 2022 May; 44(5):e2100270. PubMed ID: 35229908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.
    Wood AJ; Lin CH; Li M; Nishtala K; Alaei S; Rossello F; Sonntag C; Hersey L; Miles LB; Krisp C; Dudczig S; Fulcher AJ; Gibertini S; Conroy PJ; Siegel A; Mora M; Jusuf P; Packer NH; Currie PD
    Nat Commun; 2021 May; 12(1):2951. PubMed ID: 34012031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fukutin-Related Protein: From Pathology to Treatments.
    Ortiz-Cordero C; Azzag K; Perlingeiro RCR
    Trends Cell Biol; 2021 Mar; 31(3):197-210. PubMed ID: 33272829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies.
    Ortiz-Cordero C; Bincoletto C; Dhoke NR; Selvaraj S; Magli A; Zhou H; Kim DH; Bang AG; Perlingeiro RCR
    Stem Cell Reports; 2021 Nov; 16(11):2752-2767. PubMed ID: 34653404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies.
    Ackroyd MR; Skordis L; Kaluarachchi M; Godwin J; Prior S; Fidanboylu M; Piercy RJ; Muntoni F; Brown SC
    Brain; 2009 Feb; 132(Pt 2):439-51. PubMed ID: 19155270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.
    Dhoke NR; Kim H; Selvaraj S; Azzag K; Zhou H; Oliveira NAJ; Tungtur S; Ortiz-Cordero C; Kiley J; Lu QL; Bang AG; Perlingeiro RCR
    Cell Rep; 2021 Jul; 36(2):109360. PubMed ID: 34260922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.
    Kim J; Lana B; Torelli S; Ryan D; Catapano F; Ala P; Luft C; Stevens E; Konstantinidis E; Louzada S; Fu B; Paredes-Redondo A; Chan AE; Yang F; Stemple DL; Liu P; Ketteler R; Selwood DL; Muntoni F; Lin YY
    EMBO Rep; 2019 Nov; 20(11):e47967. PubMed ID: 31566294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional requirements for fukutin-related protein in the Golgi apparatus.
    Esapa CT; Benson MA; Schröder JE; Martin-Rendon E; Brockington M; Brown SC; Muntoni F; Kröger S; Blake DJ
    Hum Mol Genet; 2002 Dec; 11(26):3319-31. PubMed ID: 12471058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular dystrophies due to defective glycosylation of dystroglycan.
    Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
    Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of fukutin and fukutin-related protein in muscle cells.
    Matsumoto H; Noguchi S; Sugie K; Ogawa M; Murayama K; Hayashi YK; Nishino I
    J Biochem; 2004 Jun; 135(6):709-12. PubMed ID: 15213246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy.
    Vannoy CH; Leroy V; Broniowska K; Lu QL
    Sci Rep; 2019 Jul; 9(1):10070. PubMed ID: 31296900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.
    Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC
    Elife; 2021 Jan; 10():. PubMed ID: 33513091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.
    Xu L; Lu PJ; Wang CH; Keramaris E; Qiao C; Xiao B; Blake DJ; Xiao X; Lu QL
    Mol Ther; 2013 Oct; 21(10):1832-40. PubMed ID: 23817215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.